NCT02004106Cergutuzumab amunaleukinCAmetastatic/unresectable CEA+ solid tumors
…CA in patients with metastatic/unresectable CEA+ solid tumors ( NCT02004106).Methods Patients received ascending doses of CA intravenously …
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NCT02004106 ×
NCT02004106
This institution is selected. Its supporting articles are shown below.